{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:24:41Z","timestamp":1791915881025,"version":"4.3.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s13555-024-01169-1","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:02:11Z","timestamp":1714694531000},"page":"1079-1091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review"],"prefix":"10.1007","volume":"14","author":[{"given":"Elisa","family":"Molinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Gioacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Rizzetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Gambini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8052-9324","authenticated-orcid":false,"given":"Edoardo","family":"De Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Offidani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"key":"1169_CR1","doi-asserted-by":"publisher","first-page":"8428","DOI":"10.3390\/ijms24098428","volume":"24","author":"E Molinelli","year":"2023","unstructured":"Molinelli E, Gioacchini H, Sapigni C, Diotallevi F, Brisigotti V, Rizzetto G, et al. New insight into the molecular pathomechanism and immunomodulatory treatments of hidradenitis suppurativa. Int J Mol Sci. 2023;24:8428.","journal-title":"Int J Mol Sci"},{"key":"1169_CR2","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.3390\/ijerph18116131","volume":"18","author":"PV Chernyshov","year":"2021","unstructured":"Chernyshov PV, Finlay AY, Tomas-Aragones L, Poot F, Sampogna F, Marron SE, et al. Quality of life in hidradenitis suppurativa: an update. Int J Environ Res Public Health. 2021;18:6131.","journal-title":"Int J Environ Res Public Health"},{"key":"1169_CR3","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1111\/ced.13861","volume":"44","author":"L Bianchi","year":"2019","unstructured":"Bianchi L, Caposiena Caro RD, Ganzetti G, Molinelli E, Dini V, Oranges T, et al. Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort. Clin Exp Dermatol. 2019;44:e177\u201380.","journal-title":"Clin Exp Dermatol"},{"key":"1169_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/CCID.S111019","volume":"10","author":"M Napolitano","year":"2017","unstructured":"Napolitano M, Megna M, Timoshchuk E, Patruno C, Balato N, Fabbrocini G, et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol. 2017;10:105\u201315.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1169_CR5","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.jaad.2015.07.045","volume":"73","author":"E Prens","year":"2015","unstructured":"Prens E, Deckers I. Pathophysiology of hidradenitis suppurativa: an update. J Am Acad Dermatol. 2015;73:S8-11.","journal-title":"J Am Acad Dermatol"},{"key":"1169_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juh\u00e1sz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1169_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1574-695X.2012.00946.x","volume":"65","author":"S Kathju","year":"2012","unstructured":"Kathju S, Lasko L-A, Stoodley P. Considering hidradenitis suppurativa as a bacterial biofilm disease. FEMS Immunol Med Microbiol. 2012;65:385\u20139.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1169_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.5021\/ad.2012.24.4.393","volume":"24","author":"FG Bechara","year":"2012","unstructured":"Bechara FG, Sand M, Skrygan M, Kreuter A, Altmeyer P, Gambichler T. Acne inversa: evaluating antimicrobial peptides and proteins. Ann Dermatol. 2012;24:393.","journal-title":"Ann Dermatol"},{"key":"1169_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000431175","volume":"231","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, del Marmol V, Mrowietz U, Prens EP, Tzellos T, Jemec GBE. Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology. 2015;231:184\u201390.","journal-title":"Dermatology"},{"key":"1169_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15235","author":"M Napolitano","year":"2019","unstructured":"Napolitano M, Calzavara-Pinton PG, Zanca A, Bianchi L, Caposiena Caro RD, Offidani AM, et al. Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group. J Eur Acad Dermatol Venereol. 2019. https:\/\/doi.org\/10.1111\/jdv.15235.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1169_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jdv.15847","volume":"33","author":"F Lacarrubba","year":"2019","unstructured":"Lacarrubba F, Dini V, Napolitano M, Venturini M, Caposiena Caro DR, Molinelli E, et al. Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience. J Eur Acad Dermatol Venereol. 2019;33:10\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1169_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2019;81:91\u2013101.","journal-title":"J Am Acad Dermatol"},{"key":"1169_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15439","author":"E Molinelli","year":"2022","unstructured":"Molinelli E, Brisigotti V, Simonetti O, Sapigni C, D\u2019Agostino GM, Rizzetto G, et al. Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: a retrospective study. Dermatol Ther. 2022. https:\/\/doi.org\/10.1111\/dth.15439.","journal-title":"Dermatol Ther"},{"key":"1169_CR14","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/bjd.19337","volume":"183","author":"E Molinelli","year":"2020","unstructured":"Molinelli E, Brisigotti V, Simonetti O, Campanati A, Sapigni C, D\u2019Agostino GM, et al. Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance. Br J Dermatol. 2020;183:1117\u20139.","journal-title":"Br J Dermatol"},{"key":"1169_CR15","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.2017.16691","volume":"318","author":"DML Saunte","year":"2017","unstructured":"Saunte DML, Jemec GBE. Hidradenitis suppurativa. JAMA. 2017;318:2019.","journal-title":"JAMA"},{"key":"1169_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/antibiotics12060978","volume":"12","author":"E Molinelli","year":"2023","unstructured":"Molinelli E, De Simoni E, Candelora M, Sapigni C, Brisigotti V, Rizzetto G, et al. Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues. Antibiotics. 2023;12:978.","journal-title":"Antibiotics"},{"key":"1169_CR17","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3390\/antibiotics11111573","volume":"11","author":"E Molinelli","year":"2022","unstructured":"Molinelli E, Sapigni C, D\u2019Agostino GM, Brisigotti V, Rizzetto G, Bobyr I, et al. The effect of dalbavancin in moderate to severe hidradenitis suppurativa. Antibiotics. 2022;11:1573.","journal-title":"Antibiotics"},{"key":"1169_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jaad.2020.04.092","volume":"83","author":"E Molinelli","year":"2020","unstructured":"Molinelli E, Brisigotti V, Campanati A, Sapigni C, Giacchetti A, Cota C, et al. Efficacy of oral zinc and nicotinamide as maintenance therapy for mild\/moderate hidradenitis suppurativa: a controlled retrospective clinical study. J Am Acad Dermatol. 2020;83:665\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1169_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/17425255.2019.1600670","volume":"15","author":"E Molinelli","year":"2019","unstructured":"Molinelli E, Paolinelli M, Campanati A, Brisigotti V, Offidani A. Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone. Expert Opin Drug Metab Toxicol. 2019;15:367\u201379.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1169_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jaad.2021.10.060","volume":"87","author":"E Molinelli","year":"2022","unstructured":"Molinelli E, Sapigni C, Simonetti O, Brisigotti V, Giuliodori K, Offidani A. Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: a controlled prospective clinical study. J Am Acad Dermatol. 2022;87:674\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"1169_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1574886310666151014115127","volume":"11","author":"E Molinelli","year":"2016","unstructured":"Molinelli E, Campanati A, Ganzetti G, Offidani A. Biologic therapy in immune mediated inflammatory disease: basic science and clinical concepts. Curr Drug Saf. 2016;11:35\u201343.","journal-title":"Curr Drug Saf"},{"key":"1169_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jdermsci.2008.12.012","volume":"54","author":"O Simonetti","year":"2009","unstructured":"Simonetti O, Lucarini G, Campanati A, Goteri G, Zizzi A, Marconi B, et al. VEGF, survivin and NOS overexpression in psoriatic skin: critical role of nitric oxide synthases. J Dermatol Sci. 2009;54:205\u20138.","journal-title":"J Dermatol Sci"},{"key":"1169_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000247421","volume":"185","author":"O Simonetti","year":"1992","unstructured":"Simonetti O, Ferretti G, Salvi A, Offidani AM, Bossi G. Plasma lipid changes in psoriatic children. Dermatology. 1992;185:96\u2013100.","journal-title":"Dermatology"},{"key":"1169_CR24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2217\/imt-2023-0103","volume":"15","author":"CL Snyder","year":"2023","unstructured":"Snyder CL, Gibson RS, Porter ML, Kimball AB. Secukinumab in the treatment of hidradenitis suppurativa. Immunotherapy. 2023;15:1449\u201357.","journal-title":"Immunotherapy"},{"key":"1169_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaad.2019.08.089","volume":"82","author":"SR Goldburg","year":"2020","unstructured":"Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa. J Am Acad Dermatol. 2020;82:1061\u201382.","journal-title":"J Am Acad Dermatol"},{"key":"1169_CR26","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1080\/17425255.2020.1810233","volume":"16","author":"E Molinelli","year":"2020","unstructured":"Molinelli E, Sapigni C, Campanati A, Brisigotti V, Offidani A. Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa. Expert Opin Drug Metab Toxicol. 2020;16:1019\u201337.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1169_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13877","author":"U Wollina","year":"2020","unstructured":"Wollina U, Brzezinski P, Koch A, Philipp-Dormston WG. Immunomodulatory drugs alone and adjuvant to surgery for hidradenitis suppurativa\/acne inversa\u2014a narrative review. Dermatol Ther. 2020. https:\/\/doi.org\/10.1111\/dth.13877.","journal-title":"Dermatol Ther"},{"key":"1169_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2003.12.005","volume":"328","author":"J Bastien","year":"2004","unstructured":"Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene. 2004;328:1\u201316.","journal-title":"Gene"},{"key":"1169_CR29","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1080\/09546634.2017.1309349","volume":"28","author":"S Khalil","year":"2017","unstructured":"Khalil S, Bardawil T, Stephan C, Darwiche N, Abbas O, Kibbi AG, et al. Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects. J Dermatol Treat. 2017;28:684\u201396.","journal-title":"J Dermatol Treat"},{"key":"1169_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/ciia.2006.1.4.327","volume":"1","author":"S Mukherjee","year":"2006","unstructured":"Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1:327\u201348.","journal-title":"Clin Interv Aging"},{"key":"1169_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000503605","volume":"237","author":"AJ Hendricks","year":"2021","unstructured":"Hendricks AJ, Hsiao JL, Lowes MA, Shi VY. A comparison of international management guidelines for hidradenitis suppurativa. Dermatology. 2021;237:81\u201396.","journal-title":"Dermatology"},{"key":"1169_CR32","unstructured":"Pile HD, Sadiq NM. Isotretinoin. In: StatPearls. Treasure Island: StatPearls Publishing; 2023."},{"key":"1169_CR33","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0190-9622(98)70438-4","volume":"39","author":"U-W Wiegand","year":"1998","unstructured":"Wiegand U-W, Chou RC. Pharmacokinetics of oral isotretinoin. J Am Acad Dermatol. 1998;39:S8-12.","journal-title":"J Am Acad Dermatol"},{"key":"1169_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2340\/00015555-2535","volume":"97","author":"B Melnik","year":"2017","unstructured":"Melnik B. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Dermatol Venereol. 2017;97:173\u201381.","journal-title":"Acta Dermatol Venereol"},{"key":"1169_CR35","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.3390\/cells10082094","volume":"10","author":"E Scala","year":"2021","unstructured":"Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, et al. Hidradenitis suppurativa: where we are and where we are going. Cells. 2021;10:2094.","journal-title":"Cells"},{"key":"1169_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jdin.2020.05.005","volume":"1","author":"JW Frew","year":"2020","unstructured":"Frew JW. Hidradenitis suppurativa is an autoinflammatory keratinization disease: a review of the clinical, histologic, and molecular evidence. JAAD Int. 2020;1:62\u201372.","journal-title":"JAAD Int"},{"key":"1169_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5114\/pdia.2014.40655","volume":"1","author":"B Bergler-Czop","year":"2014","unstructured":"Bergler-Czop B, Brzezi\u0144ska-Wcis\u0142o L. Pro-inflammatory cytokines in patients with various kinds of acne treated with isotretinoin. Adv Dermatol Allergol. 2014;1:21\u20138.","journal-title":"Adv Dermatol Allergol"},{"key":"1169_CR38","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1038\/jid.2012.111","volume":"132","author":"MC Dispenza","year":"2012","unstructured":"Dispenza MC, Wolpert EB, Gilliland KL, Dai JP, Cong Z, Nelson AM, et al. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Investig Dermatol. 2012;132:2198\u2013205.","journal-title":"J Investig Dermatol"},{"key":"1169_CR39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/jdv.16071","volume":"34","author":"S Hessam","year":"2020","unstructured":"Hessam S, Gambichler T, H\u00f6xtermann S, Skrygan M, Sand M, Garcovich S, et al. Frequency of circulating subpopulations of T-regulatory cells in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020;34:834\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1169_CR40","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/exd.14798","volume":"32","author":"ZT Nolan","year":"2023","unstructured":"Nolan ZT, Banerjee K, Cong Z, Gettle SL, Longenecker AL, Kawasawa YI, et al. Treatment response to isotretinoin correlates with specific shifts in Cutibacterium acnes strain composition within the follicular microbiome. Exp Dermatol. 2023;32:955\u201364.","journal-title":"Exp Dermatol"},{"key":"1169_CR41","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","volume":"153","author":"HC Ring","year":"2017","unstructured":"Ring HC, Thorsen J, Saunte DM, Lilje B, Bay L, Riis PT, et al. The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol. 2017;153:897.","journal-title":"JAMA Dermatol"},{"key":"1169_CR42","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1365-2133.2011.10224.x","volume":"164","author":"S Kamp","year":"2011","unstructured":"Kamp S, Fiehn AM, Stenderup K, Rosada C, Pakkenberg B, Kemp K, et al. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol. 2011;164:1017\u201322.","journal-title":"Br J Dermatol"},{"key":"1169_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.annder.2018.07.020","volume":"146","author":"F Poli","year":"2019","unstructured":"Poli F, Revuz J. \u00abPouss\u00e9es inflammatoires d\u2019acn\u00e9\u202f\u00bb sous isotr\u00e9tino\u00efne r\u00e9v\u00e9lant une hidrad\u00e9nite suppur\u00e9e: 4 cas. Ann Dermatol Venereol. 2019;146:4\u20138.","journal-title":"Ann Dermatol Venereol"},{"key":"1169_CR44","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/ced.13944","volume":"44","author":"CG Gallagher","year":"2019","unstructured":"Gallagher CG, Kirthi SK, Cotter CC, Revuz JR, Tobin AMT. Could isotretinoin flare hidradenitis suppurativa? A case series. Clin Exp Dermatol. 2019;44:777\u201380.","journal-title":"Clin Exp Dermatol"},{"key":"1169_CR45","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1111\/ced.13956","volume":"44","author":"RD Caposiena Caro","year":"2019","unstructured":"Caposiena Caro RD, Bianchi L. Can retinoids flare hidradenitis suppurativa? A further case series. Clin Exp Dermatol. 2019;44:e153\u20134.","journal-title":"Clin Exp Dermatol"},{"key":"1169_CR46","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1111\/ced.13953","volume":"44","author":"A-HR J\u00f8rgensen","year":"2019","unstructured":"J\u00f8rgensen A-HR, Thomsen SF, Ring HC. Isotretinoin and hidradenitis suppurativa. Clin Exp Dermatol. 2019;44:e155\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"1169_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000182261","volume":"218","author":"A Soria","year":"2009","unstructured":"Soria A, Canoui-Poitrine F, Wolkenstein P, Poli F, Gabison G, Pouget F, et al. Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients\u2019 outcome assessment. Dermatology. 2009;218:134\u20135.","journal-title":"Dermatology"},{"key":"1169_CR48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000484408","volume":"233","author":"V De Vita","year":"2017","unstructured":"De Vita V, Melnik BC. The magnitude of mTORC1 signalling may predict the response to isotretinoin treatment in patients with hidradenitis suppurativa. Dermatology. 2017;233:399\u2013400.","journal-title":"Dermatology"},{"key":"1169_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15271","author":"C Marasca","year":"2019","unstructured":"Marasca C, Balato A, Annunziata MC, Cacciapuoti S, Fabbrocini G. Insulin resistance, mTOR and hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019. https:\/\/doi.org\/10.1111\/jdv.15271.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1169_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15160","author":"A Balato","year":"2019","unstructured":"Balato A, Caiazzo G, Annunziata MC, Marasca C, Scala E, Cacciapuoti S, et al. Anti-TNF-\u03b1 therapy modulates mTORC1 signalling in hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019. https:\/\/doi.org\/10.1111\/jdv.15160.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1169_CR51","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40257-022-00725-9","volume":"23","author":"K Bouwman","year":"2022","unstructured":"Bouwman K, Aarts P, Dudink K, Hao J, Alizadeh BZ, Prens LM, et al. Drug survival of oral retinoids in hidradenitis suppurativa: a real-life cohort study. Am J Clin Dermatol. 2022;23:905\u201314.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"1169_CR52","first-page":"87","volume":"64","author":"LFFDA Libow","year":"1999","unstructured":"Libow LFFDA. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. Cutis. 1999;64(2):87\u201390.","journal-title":"Cutis"},{"key":"1169_CR53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000477207","volume":"233","author":"CM Huang","year":"2017","unstructured":"Huang CM, Kirchhof MG. A new perspective on isotretinoin treatment of hidradenitis suppurativa: a retrospective chart review of patient outcomes. Dermatology. 2017;233:120\u20135.","journal-title":"Dermatology"},{"key":"1169_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0190-9622(99)70530-X","volume":"40","author":"J Boer","year":"1999","unstructured":"Boer J, van Gemert MJP. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. 1999;40:73\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"1169_CR55","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/09546634.2019.1670779","volume":"32","author":"N Patel","year":"2021","unstructured":"Patel N, McKenzie SA, Harview CL, Truong AK, Shi VY, Chen L, et al. Isotretinoin in the treatment of hidradenitis suppurativa: a retrospective study. J Dermatol Treat. 2021;32:473\u20135.","journal-title":"J Dermatol Treat"},{"key":"1169_CR56","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/1203475418823529","volume":"23","author":"ML McPhie","year":"2019","unstructured":"McPhie ML, Bridgman AC, Kirchhof MG. Combination therapies for hidradenitis suppurativa: a retrospective chart review of 31 patients. J Cutan Med Surg. 2019;23:270\u20136.","journal-title":"J Cutan Med Surg"},{"key":"1169_CR57","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00296-019-04434-1","volume":"39","author":"BN Coskun","year":"2019","unstructured":"Coskun BN, Yagiz B, Pehlivan Y, Dalkilic E. Isotretinoin-induced sacroiliitis in patients with hidradenitis suppurativa: a case-based review. Rheumatol Int. 2019;39:2159\u201365.","journal-title":"Rheumatol Int"},{"key":"1169_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jad.2009.09.005","volume":"122","author":"LC Schaffer","year":"2010","unstructured":"Schaffer LC, Schaffer CB, Hunter S, Miller A. Psychiatric reactions to isotretinoin in patients with bipolar disorder. J Affect Disord. 2010;122:306\u20138.","journal-title":"J Affect Disord"},{"key":"1169_CR59","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000504535","volume":"236","author":"D Tzur Bitan","year":"2020","unstructured":"Tzur Bitan D, Berzin D, Cohen A. Hidradenitis suppurativa and bipolar disorders: a population-based study. Dermatology. 2020;236:298\u2013304.","journal-title":"Dermatology"},{"key":"1169_CR60","unstructured":"Zito PM, Mazzoni T. Acitretin. In: StatPearls. Treasure Island: StatPearls Publishing; 2023."},{"key":"1169_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21194","author":"G Ganzetti","year":"2014","unstructured":"Ganzetti G, Campanati A, Santarelli A, Pozzi V, Molinelli E, Minnetti I, et al. Periodontal disease: an oral manifestation of psoriasis or an occasional finding? Drug Dev Res. 2014. https:\/\/doi.org\/10.1002\/ddr.21194.","journal-title":"Drug Dev Res"},{"key":"1169_CR62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2165\/00003495-199243040-00010","volume":"43","author":"T Pilkington","year":"1992","unstructured":"Pilkington T, Brogden RN. Acitretin. Drugs. 1992;43:597\u2013627.","journal-title":"Drugs"},{"key":"1169_CR63","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/dth.12086","volume":"26","author":"NEG Ortiz","year":"2013","unstructured":"Ortiz NEG, Nijhawan RI, Weinberg JM. Acitretin. Dermatol Ther. 2013;26:390\u20139.","journal-title":"Dermatol Ther"},{"key":"1169_CR64","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.1177\/1203475417733414","volume":"21","author":"LC Guenther","year":"2017","unstructured":"Guenther LC, Kunynetz R, Lynde CW, Sibbald RG, Toole J, Vender R, et al. Acitretin use in dermatology. J Cutan Med Surg. 2017;21:2S-12S.","journal-title":"J Cutan Med Surg"},{"key":"1169_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106045","volume":"79","author":"J Tu","year":"2020","unstructured":"Tu J, Yin Z, Guo J, He F, Long F, Yin Z. Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating I\u03baB\u03b6. Int Immunopharmacol. 2020;79: 106045.","journal-title":"Int Immunopharmacol"},{"key":"1169_CR66","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","volume":"164","author":"J Boer","year":"2011","unstructured":"Boer J, Nazary M. Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? Br J Dermatol. 2011;164:170\u20135.","journal-title":"Br J Dermatol"},{"key":"1169_CR67","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/bjd.12884","volume":"171","author":"\u0141 Matusiak","year":"2014","unstructured":"Matusiak \u0141, Bieniek A, Szepietowski JC. Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients. Br J Dermatol. 2014;171:170\u20134.","journal-title":"Br J Dermatol"},{"key":"1169_CR68","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000526019","volume":"239","author":"M S\u00e1nchez-D\u00edaz","year":"2023","unstructured":"S\u00e1nchez-D\u00edaz M, D\u00edaz-Calvillo P, Rodr\u00edguez-Pozo J\u00c1, Arias-Santiago S, Molina-Leyva A. Effectiveness and safety of acitretin for the treatment of hidradenitis suppurativa, predictors of clinical response: a cohort study. Dermatology. 2023;239:52\u20139.","journal-title":"Dermatology"},{"key":"1169_CR69","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1203475416659858","volume":"21","author":"MG Tan","year":"2017","unstructured":"Tan MG, Shear NH, Walsh S, Alhusayen R. Acitretin. J Cutan Med Surg. 2017;21:48\u201353.","journal-title":"J Cutan Med Surg"},{"key":"1169_CR70","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18706","author":"E Molinelli","year":"2023","unstructured":"Molinelli E, Sapigni C, Simonetti O, D\u2019Agostino GM, Brisigotti V, Rizzetto G, et al. Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2023. https:\/\/doi.org\/10.1111\/jdv.18706.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1169_CR71","doi-asserted-by":"publisher","first-page":"650","DOI":"10.4103\/0019-5154.91821","volume":"56","author":"N Puri","year":"2011","unstructured":"Puri N, Talwar A. A study on the management of hidradenitis suppurativa with retinoids and surgical excision. Indian J Dermatol. 2011;56:650.","journal-title":"Indian J Dermatol"},{"key":"1169_CR72","doi-asserted-by":"publisher","first-page":"445","DOI":"10.25259\/IJDVL_471_19","volume":"88","author":"A-W Chen","year":"2022","unstructured":"Chen A-W, Chen Z, Bai X-M, Luo X-Y, Wang H. Successful treatment of early-onset hidradenitis suppurativa with acitretin in an infant with a novel mutation in PSENEN gene. Indian J Dermatol Venereol Leprol. 2022;88:445.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1169_CR73","doi-asserted-by":"publisher","DOI":"10.23736\/S2784-8671.20.06568-2","author":"I D\u2019Ambra","year":"2022","unstructured":"D\u2019Ambra I, Caccavale S, Ronchi A, Franco R, Argenziano G. A case of hidradenitis suppurativa and Darier disease in a patient treated with acitretin: how to kill two birds with one stone. Italian J Dermatol Venereol. 2022. https:\/\/doi.org\/10.23736\/S2784-8671.20.06568-2.","journal-title":"Italian J Dermatol Venereol."},{"issue":"4","key":"1169_CR74","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/ijd.ijd_328_21","volume":"67","author":"SS Sachdev","year":"2022","unstructured":"Sachdev SS, Jamil A, Gunabalasingam P, Safdar NA. The effects of acitretin on insulin resistance, glucose metabolism, and lipid levels in patients with psoriasis. Indian J Dermatol. 2022;67(4):349\u201354.","journal-title":"Indian J Dermatol"},{"key":"1169_CR75","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2340\/00015555-1256","volume":"92","author":"T Diepgen","year":"2012","unstructured":"Diepgen T, Pfarr E, Zimmermann T. Efficacy and tolerability of alitretinoin for chronic hand eczema under daily practice conditions: results of the TOCCATA open study comprising 680 patients. Acta Derm Venereol. 2012;92:251\u20135.","journal-title":"Acta Derm Venereol"},{"key":"1169_CR76","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1517\/13543784.17.3.437","volume":"17","author":"C Cheng","year":"2008","unstructured":"Cheng C, Michaels J, Scheinfeld N. Alitretinoin: a comprehensive review. Expert Opin Investig Drugs. 2008;17:437\u201343.","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"1169_CR77","first-page":"155","volume":"150","author":"R Verdolini","year":"2015","unstructured":"Verdolini R, Simonacci F, Menon S, Pavlou P, Mannello B. Alitretinoin: a useful agent in the treatment of hidradenitis suppurativa, especially in women of child-bearing age. G Ital Dermatol Venereol. 2015;150(2):155\u201362 (Epub 2014 Jun 13).","journal-title":"G Ital Dermatol Venereol"},{"key":"1169_CR78","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4103\/0019-5154.164426","volume":"60","author":"A Bubna","year":"2015","unstructured":"Bubna A. Alitretinoin in dermatology\u2014an update. Indian J Dermatol. 2015;60:520.","journal-title":"Indian J Dermatol"},{"key":"1169_CR79","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2340\/00015555-1499","volume":"93","author":"S Prasad","year":"2013","unstructured":"Prasad S, Bygum A. Successful treatment with alitretinoin of dissecting cellulitis of the scalp in keratitis-ichthyosis-deafness syndrome. Acta Derm Venereol. 2013;93:473\u20134.","journal-title":"Acta Derm Venereol"},{"key":"1169_CR80","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/12034754211035091","volume":"26","author":"M Motamedi","year":"2022","unstructured":"Motamedi M, Chehade A, Sanghera R, Grewal P. A clinician\u2019s guide to topical retinoids. J Cutan Med Surg. 2022;26:71\u20138.","journal-title":"J Cutan Med Surg"},{"key":"1169_CR81","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1610-0387.2008.06741.x","volume":"6","author":"A Thielitz","year":"2008","unstructured":"Thielitz A, Abdel-Naser MB, Fluhr JW, Zouboulis CC, Gollnick H. Topical retinoids in acne\u2014an evidence-based overview. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 2008;6:1023\u201331.","journal-title":"JDDG Journal der Deutschen Dermatologischen Gesellschaft."},{"key":"1169_CR82","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/bjd.14053","volume":"173","author":"YC Kaplan","year":"2015","unstructured":"Kaplan YC, Ozsarfati J, Etwel F, Nickel C, Nulman I, Koren G. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis. Br J Dermatol. 2015;173:1132\u201341.","journal-title":"Br J Dermatol"},{"key":"1169_CR83","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.det.2006.01.001","volume":"24","author":"SA Leachman","year":"2006","unstructured":"Leachman SA, Reed BR. The use of dermatologic drugs in pregnancy and lactation. Dermatol Clin. 2006;24:167\u201397.","journal-title":"Dermatol Clin"},{"key":"1169_CR84","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.clindermatol.2014.12.007","volume":"33","author":"N Scheinfeld","year":"2015","unstructured":"Scheinfeld N. Hidradenitis suppurativa in prepubescent and pubescent children. Clin Dermatol. 2015;33:316\u20139.","journal-title":"Clin Dermatol"},{"issue":"2","key":"1169_CR85","first-page":"192","volume":"13","author":"A Karpouzis","year":"2003","unstructured":"Karpouzis A, Giatromanolaki A, Sivridis E, Kouskoukis C. Perifolliculitis capitis abscedens et suffodiens successfully controlled with topical isotretinoin. Eur J Dermatol. 2003;13(2):192\u20135.","journal-title":"Eur J Dermatol"},{"key":"1169_CR86","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/jcm11030670","volume":"11","author":"K Das","year":"2022","unstructured":"Das K, Daveluy S, Kroumpouzos G, Agarwal K, Podder I, Farnbach K, et al. Efficacy and toxicity of classical immunosuppressants, retinoids and biologics in hidradenitis suppurativa. J Clin Med. 2022;11:670.","journal-title":"J Clin Med"},{"key":"1169_CR87","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000512032","volume":"7","author":"C Marasca","year":"2021","unstructured":"Marasca C, Fabbrocini G, Abategiovanni L, Camela E, Nocerino M, Di Guida A, et al. Adalimumab in the management of isotretinoin-induced acne fulminans: report of a case. Skin Appendage Disord. 2021;7:115\u20139.","journal-title":"Skin Appendage Disord"},{"key":"1169_CR88","unstructured":"Clinicaltrials.gov and Pubmed.ncbi.nlm.nih.gov."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01169-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T18:28:48Z","timestamp":1731868128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01169-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1169"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01169-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"8 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Elisa Molinelli, Helena Gioacchini, Andrea Marani, Daisy Gambini, Giulio Rizzetto, Edoardo De Simoni, Annamaria Offidani, Oriana Simonetti have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}